Fibronectin type III domain based scaffold compositions, methods and uses
First Claim
Patent Images
1. A method of constructing a library of a protein scaffold based on a fibronectin type III (FN3) domain derived from a consensus sequence of an FN3 domain, comprising the steps of:
- providing a polypeptide derived from a consensus sequence of an FN3 domain having at least 90% identity to the amino acid sequence of SEQ ID NO;
16; and
introducing diversity into copies of the polypeptide to form the protein scaffold library.
1 Assignment
0 Petitions
Accused Products
Abstract
A protein scaffold based on a consensus sequence of fibronectin type III (FN3) proteins, such as the tenth FN3 repeat from human fibronectin (human Tenascin), including isolated nucleic acids that encode a protein scaffold, vectors, host cells, and methods of making and using thereof have applications in diagnostic and/or therapeutic compositions, methods and devices. In particular, protein scaffold molecules binding to IgG have been identified as useful for diagnostic and/or therapeutic applications.
38 Citations
3 Claims
-
1. A method of constructing a library of a protein scaffold based on a fibronectin type III (FN3) domain derived from a consensus sequence of an FN3 domain, comprising the steps of:
-
providing a polypeptide derived from a consensus sequence of an FN3 domain having at least 90% identity to the amino acid sequence of SEQ ID NO;
16; andintroducing diversity into copies of the polypeptide to form the protein scaffold library.
-
-
2. A method of constructing a library of a protein scaffold based on a fibronectin type III (FN3) domain, comprising the steps of:
-
providing a polypeptide having the amino acid sequence of SEQ ID NO;
16; andintroducing diversity into copies of the polypeptide having the amino acid sequence of SEQ ID NO;
16 to form the protein scaffold library. - View Dependent Claims (3)
-
Specification